In Brief: U.S. Surgical/Ethicon
This article was originally published in The Gray Sheet
Executive Summary
U.S. Surgical/Ethicon: Dismissal by the federal court of appeals of Johnson & Johnson subsidiary Ethicon's trocar patent infringement claims against U.S. Surgical allows USSC to proceed to trial with its own patent infringement claims against Ethicon, the firm states in a Feb. 4 release. The appeals court dismissal affirms the earlier dismissal by the U.S. District Court in Hartford, Connecticut ("The Gray Sheet" Feb. 17, 1997, In Brief). The three patents in question involve all of the safety-shielded trocars manufactured by Ethicon since 1990. "Damages could exceed $500 mil. before trebling" if USSC prevails, the firm claims...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.